John Mendlein

Companies

• Fate TherapeuticsBoard member Sep 30, 2013 to now¹
• Omega Therapeutics, Inc.Board member Jul 29, 2021 to Jun 21, 2024²
• aTyr PharmaBoard member May 8, 2015 to May 10, 2019³
• ModernaOfficer Dec 7, 2018 to Dec 7, 2018⁴
• aTyr PharmaChief executive officer May 6, 2015 to Sep 5, 2017⁵
• Editas MedicineBoard member Feb 2, 2016 to Jun 19, 2017⁶
• aTyr PharmaOfficer Oct 5, 2015 to Oct 5, 2015⁷
• aTyr PharmaChair May 6, 2015 to May 14, 2015⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• FTFate Therapeutics FATE311,231 shares⁸$585.1K at $1.88Jan 19, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 19, 2023Exercised options 28,461 shares at $1.37 of Fate Therapeutics⁸
• Jan 13, 2023Bought 36,631 shares at $5.43 of Fate Therapeutics⁹
• Jan 11, 2023Bought 88,048 shares at $5.67 of Fate Therapeutics⁹
• Jun 9, 2022Granted 8,650 shares of Fate Therapeutics¹⁰
• Jun 3, 2022Sold 1,364 shares at $22.79 of Fate Therapeutics¹¹
• Mar 10, 2022Sold 12,069 shares at $35.48 of Fate Therapeutics¹²
• Mar 10, 2022Sold 19,493 shares at $34.73 of Fate Therapeutics¹²
• Mar 10, 2022Exercised options 31,562 shares at $1.63 of Fate Therapeutics¹²